Abstract and Introduction Rationale for i.v. Antihypertensive Selection Clinical Pharmacology of i.v. Antihypertensives References There are potential concerns with the use of sodium nitroprusside ...

Purpose. Intravenous antihypertensive agents for the treatment of hypertensive emergencies are reviewed. Summary. An estimated 500,000 people in the United States experience a hypertensive crisis ...

Therefore, intravenous antihypertensive agents are often used to maximise efficacy because of time-sensitive reperfusion treatment metrics (eg, door-to-needle time). For several reasons, we caution ...

Tourniquet-induced hypertension (TH) is still a challenging problem, and different strategies like peripheral nerve blocks, ...

Deprescribing antihypertensive medication is not associated with the risk for hospitalization for myocardial infarction (MI) or stroke in long-term care residents, according to a study published ...

The estimated unadjusted cumulative incidence did not differ between long-term care residents who were deprescribed or continued antihypertensives. Michelle C. Odden, Ph.D., from Stanford University ...

Deprescribing antihypertensive medication is not associated with the risk for hospitalization for myocardial infarction (MI) or stroke in long-term care residents. HealthDay News — Deprescribing ...

Over 2 years, a similar estimated unadjusted cumulative incidence of stroke or MI hospitalization was seen for residents who were and were not deprescribed antihypertensives (11.2% vs 8.8%).

The projected revenue for the Anti-Hypertensive Drugs market in Albania is expected to reach US$1.62m in 2024. It is anticipated that the revenue will experience an annual growth rate (CAGR 2024 ...

TUESDAY, Dec. 3, 2024 (HealthDay News) -- Deprescribing antihypertensive medication is not associated with the risk for hospitalization for myocardial infarction (MI) or stroke in long-term care ...